You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ):獲得3項發明專利證書
格隆匯 06-23 16:04

格隆匯6月23日丨迪瑞醫療(300396.SZ)公佈,公司於近日收到由中華人民共和國國家知識產權局頒發的3項《發明專利證書》,分別為一種試劑瓶夾持組件、自動加載機構及其加載方法,一種液路除氣泡裝置及方法,一種用於試管的無序上料裝置。

上述專利均為公司自主研發,分別應用於公司化學發光免疫分析、血細胞分析及標準化實驗室產品線中。一種試劑瓶夾持組件、自動加載機構及其加載方法的應用可以實現對試劑瓶的自動夾持和鬆開,避免人為接觸試劑產生的污染,節省人力及時間;一種液路除氣泡裝置及方法的應用具有除氣泡迅速、控制簡單及成本低的優點;一種用於試管的無序上料裝置的應用可以使儀器運行更為流暢,能夠降低故障率,提高工作效率

公司長期堅持儀器和試劑均衡發展始終注重自主研發和技術創新,未來,公司將繼續開發補充新技術項目,助力公司穩健快速發展上述發明專利的取得不會對公司近期生產經營產生重大影響,但有利於發揮公司自主知識產權技術優勢,完善知識產權保護體系,從而增強公司核心競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account